» Articles » PMID: 22773469

Histomorphometry of Feline Chronic Kidney Disease and Correlation with Markers of Renal Dysfunction

Overview
Journal Vet Pathol
Date 2012 Jul 10
PMID 22773469
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease is common in geriatric cats, but most cases have nonspecific renal lesions, and few studies have correlated these lesions with clinicopathological markers of renal dysfunction. The aim of this study was to identify the lesions best correlated with renal function and likely mediators of disease progression in cats with chronic kidney disease. Cats were recruited through 2 first-opinion practices between 1992 and 2010. When postmortem examinations were authorized, renal tissues were preserved in formalin. Sections were evaluated by a pathologist masked to all clinicopathological data. They were scored semiquantitatively for the severity of glomerulosclerosis, interstitial inflammation, and fibrosis. Glomerular volume was measured using image analysis; the percentage of glomeruli that were obsolescent was recorded. Sections were assessed for hyperplastic arteriolosclerosis and tubular mineralization. Kidneys from 80 cats with plasma biochemical data from the last 2 months of life were included in the study. Multivariable linear regression (P < .05) was used to assess the association of lesions with clinicopathological data obtained close to death. Interstitial fibrosis was the lesion best correlated with the severity of azotemia, hyperphosphatemia, and anemia. Proteinuria was associated with interstitial fibrosis and glomerular hypertrophy, whereas higher time-averaged systolic blood pressure was associated with glomerulosclerosis and hyperplastic arteriolosclerosis.

Citing Articles

Unraveling TGF-β1's Role in Mediating Fibrosis and Cell Death in Feline Kidney Cells.

Intachat C, Chuammitri P, Sornpet B, Patchanee P, Manachai N, Piyarungsri K Animals (Basel). 2025; 15(2).

PMID: 39858257 PMC: 11758325. DOI: 10.3390/ani15020257.


Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease.

Van Mulders L, Vanden Broecke E, De Paepe E, Mortier F, Vanhaecke L, Daminet S Vet Q. 2025; 45(1):1-15.

PMID: 39745207 PMC: 11703532. DOI: 10.1080/01652176.2024.2447601.


Impaired renal transporter gene expression and uremic toxin excretion as aging hallmarks in cats with naturally occurring chronic kidney disease.

Li Q, Holzwarth J, Smith B, Karaz S, Membrez M, Sorrentino V Aging (Albany NY). 2024; 16(22):13588-13607.

PMID: 39729035 PMC: 11723653. DOI: 10.18632/aging.206176.


Sodium glucose transporter 2 inhibitors: Will these drugs benefit non-diabetic veterinary patients with cardiac and kidney diseases?.

Elliott J, Oyama M J Vet Pharmacol Ther. 2024; 48 Suppl 1():1-18.

PMID: 39001645 PMC: 11737021. DOI: 10.1111/jvp.13472.


Hemogram-Derived Inflammatory Markers in Cats with Chronic Kidney Disease.

Krofic Zel M, Nemec Svete A, Tozon N, Pavlin D Animals (Basel). 2024; 14(12).

PMID: 38929432 PMC: 11200498. DOI: 10.3390/ani14121813.